IMC’s Obligations Clause Samples

IMC’s Obligations. 1. The main scope of IMC's work shall be the development, optimization and preparation of coated medical devices, in particular implants for the neurovascular intervention ("Development Work"). 2. The modification of such stents will, in particular, include coating of the stents xxxx xxxxxxxxxxxxxx("Coating Process"). The scope of the work also includes a characterization of the Coating Process, including the amount xxxxxx xxxxxx xxthe coating for each batch of the devices provided by Acandis, development of methods for characterizing coating homogeneity, thickness and, stability, as well as other biological or physical tests, in the scope of the capabilities of IMC. The Coating Process parameters shall be regularly recorded in order to allow to reproduce the coating by Acandis in accordance with the provisions of the Agreement. 3. As of Effective Date the Development Work, that IMC shall provide regarding the Technology, shall in particular, but not exclusively, include the following: a. Substance development or optimization b. Coating process development or optimization c. Coating of samples for internal and external tests d. Development or optimization of further processes (e.g. conditioning, drying,) e. Characterization of coating f. In vitro test of coating g. periodic reports upon the development progress/status (IMC will prepare and maintain records in accordance with standard scientific practice and shall provide Acandis with a confidential report of all relevant data, results, information and methods related to the development of Technology for its evaluation and tests) h. Know-how transfer 4. The Parties shall jointly agree on the goals, terms, requirements and appropriate time schedule for each new and/or progressed development step. IMC Project Manager shall notify Acandis Project Manager promptly in the event any delay in achieving one or more Work Packages ("WP") (as defined in respective Project Plan) can be anticipated. IMC shall devote appropriate attention to the developments. Furthermore, upon Acandis' request, IMC shall start the Coating Process for the modification of any stent delivered from Acandis for the receipt of Deliverables without undue delay. 5. The development and Coating Process shall be carried out at IMC's place of business. IMC shall send the modified stents/Deliverables to Acandis' address by registered mail. Any shipment costs, customs duty and appropriate insurance costs, if applicable, will be invoiced by IMC separat...